EXEL - Company ID 0000939767
EXELIXIS, INC. trades as EXEL and has a market capitalization of $14.28 B, making it the #765 largest US-listed company by market value. In its fiscal 2026 annual report the company posted revenue of $2.32B, up 7.0% from the prior year and net income of $782.60M. This page tracks EXELIXIS, INC. through 2,488 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-07-09
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 10 fiscal years EXELIXIS, INC.'s revenue grew from $191.45M to $2.32B, a compound annual growth rate of 28.3%. Net profit margin expanded from -36.7% to 33.7% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Insider sale notice | 144 | 2026-05-26 |
| Insider trade | 4 | 2026-05-22 |
| Insider sale notice | 144 | 2026-05-20 |
| Insider trade | 4 | 2026-05-19 |
| Insider trade | 4 | 2026-05-19 |
| Insider trade | 4 | 2026-05-19 |
| Insider trade | 4 | 2026-05-19 |
| Insider trade | 4 | 2026-05-19 |
Exelixis Announces Presentations at ASCO 2026 Highlighting Ongoing Studies in Diverse Tumor Types | Exelixis, Inc.
Exelixis Announces Clinical Development Collaboration with Merck for Phase 3 STELLAR-316 Pivotal Trial for Patients with Colorectal Cancer | Exelixis, Inc.
Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in May | Exelixis, Inc.
Exelixis Announces First Quarter 2026 Financial Results and Provides Corporate Update | Exelixis, Inc.
– Conference Call and Webcast to Follow at 5:00 p.m. ET / 2:00 p.m. PT –
The largest companies sharing EXELIXIS, INC.'s SEC industry classification (biological products, (no diagnostic substances)).
EXELIXIS, INC. (EXEL) has a market capitalization of $14.28 B as of 2026-07-09, ranking #765 among US-listed companies.
EXELIXIS, INC. reported revenue of $2.32B for fiscal year 2026, an increase of 7.0% year over year.
Yes. EXELIXIS, INC. reported net income of $782.60M in its latest fiscal year.